Trials / Completed
CompletedNCT01105793
An Open-Label, MultiCenter Evaluation of the Use of Topically Administered FP1198 in Subjects With Pain Associated With Cyclic Mastalgia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- FemmePharma Global Healthcare, Inc. · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the safety of topical FP1198 for the treatment of moderate to severe cyclic breast pain (cyclic mastalgia) and to examine the clinical activity of FP1198.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Danazol | High dose FP1198 applied once daily to both breasts for 6 treatment cycles. |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2010-04-16
- Last updated
- 2011-10-26
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01105793. Inclusion in this directory is not an endorsement.